Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons

Wenjuan Shen,Renbin Qi,Jing Zhang,Zhigang Wang,Huadong Wang,Chaofeng Hu,Yanru Zhao,Man Bie,Yanping Wang,Yongmei Fu,Mengfei Chen,Daxiang Lu

DOI: https://doi.org/10.1016/j.brainresbull.2012.04.010

IF: 3.715

2012-01-01

Brain Research Bulletin

Abstract:Pro-inflammatory factors released by activated microglia may contribute to the progression of neurodegenerative diseases. As a natural phenolic acid, chlorogenic acid (CGA) has been shown to have anti-inflammatory properties. However, it is unclear whether CGA has the ability to mediate microglial activation. The present study investigated the role of CGA in lipopolysaccharide (LPS)-stimulated microglia. Our data demonstrated that CGA significantly suppressed NO production and TNF-alpha release in U'S-stimulated primary microglia. In addition, CGA decreased LPS-stimulated phosphorylation and degradation of inhibitory kappa B-alpha (I kappa B alpha), and prevented translocation of nuclear factor-kappaB (NF-kappa B). Furthermore, CGA prevented neurotoxicity caused by microglial activation and ultimately improved survival of dopaminergic (DA) neuron. Finally, in vivo data showed that CGA pretreatment attenuated LPS-induced IL-1 beta and TNF-alpha release in substantia nigra (SN). Our results suggested that the pretreatment of CGA significantly inhibits the microglial activation, and CGA may be neuroprotective for pro-inflammatory factor-mediated neurodegenerative disorders. (C) 2012 Elsevier Inc. All rights reserved.